Functional Electrical Stimulation (FES) Assisted Walking: Enhancement of Walking Function After Stroke

Toronto Rehabilitation Institute

Status and phase

Unknown

Phase 4

Conditions

Stroke

Treatments

Device: Compex Motion Stimulator

Study type

Interventional

Funder types

Other

Identifiers

NCT00552916

SRA 5973

Details and patient eligibility

About

The purpose of this study is to determine if a form of exercise,known as electrical stimulation can improve walking function and other important health outcomes. The hypothesis is that electrical stimulation can enhance the ability to walk for stroke survivors who are unable to walk on their on their own.

Full description

A stroke is a devastating life event, that can result in permanent disability. Many people who survive a stroke will experience paralysis on one side of their body. The muscles in one leg may become weaker or stiff to the point that the person can barely walk. Functional electrical stimulation (FES) is an intervention that applies short current pulses to muscles and causes them to contract. Previous work done by our team has used FES in the spinal cord injured population to help restore functions such as walking and grasping by contracting groups of paralyzed muscles in an orchestrated manner. This study seeks to explore whether a thrice weekly FES-assisted walking intervention for a 8 week period can stimulate or improve walking ability in individuals with severe lower extremity paralysis secondary to a stroke. This will subsequently promote opportunities for enhanced social participation and quality of life i.e. enhanced balance, increased independence of activities of daily living etc. for stroke consumers. Comparison: 40 individuals with severe hemiplegia will be randomized to either a thrice weekly control (false) FES training regimen OR a thrice weekly intervention (true) FES training regimen. Prior to randomization, participants will be stratified according to their ability to ambulate (walk). This study will determine if FES can improve or enhance walking ability associated with stroke after 8 weeks of training, and after 4-month follow-up period.

Enrollment

40 estimated patients

Sex

All

Ages

Under 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Hemiplegic stroke at least 12 months prior to joining the study.
Age 65 years or greater.
Ability to follow instructions and to devote his/her attention to therapy.
Ability to understand instructions in English and able to provide informed consent.

Exclusion criteria

Severe difficulties with attention such that informed consent cannot be obtained, or that safety or communication would be comprised.
Ability to walk more that 10 meters during a two minute walk with an average speed greater than 0.8 m/s.
The presence of skin rashes, allergies or bruises where electrodes would be placed.
History of seizures, edema in paralyzed limbs or co-morbidities such as Parkinson's Disease, cancer or osteoarthritis to be confirmed by attending physiatrist.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Other group

Description:

Participants will be randomized to either an intervention arm where they will receive 'true' FES and the other control arm where they will receive 'false' FES. The sham group will receive 'false' FES.

Treatment:

Device: Compex Motion Stimulator

Other group

Description:

The intervention group will receive 'true' FES

Treatment:

Device: Compex Motion Stimulator